ARCHITECT I2000SR ANALYZER
Report
- Report Number
- 1628664-2009-00241
- Event Type
- Malfunction
- Date Received
- June 25, 2009
- Date of Event
- June 9, 2009
- Report Date
- June 9, 2009
- Manufacturer
- ABBOTT MANUFACTURING, INC.
- Product Code
- JJE
- PMA / PMN Number
- K983212
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- OTHER
Narratives
(B)(4). CONCOMITANT MEDICAL PRODUCTS AND THERAPY DATES, CMV IGG REAGENT WAS ENTERED EVALUATION, (OPTICS BOARD, TUBING). THERE WAS NO ADVERSE IMPACT TO PATIENT RESULTS DUE TO THE ERRATIC RESULTS. THE FSR REPLACED AND ADJUSTED MULTIPLE PARTS ON THE I2000SR ANALYZER. THE FSR TIGHTENED LOOSE TUBING, REPLACED THE CMIA OPTICS BOARD, REPLACED WASH ZONE PROBES AND REPLACED THE SAMPLE VALVE SYRINGE TO FINALLY RESOLVE THE ERRATIC RESULTS ISSUE. THE FSR DOCUMENTED THE I2000SR WAS WORKING ACCORDING TO EXPECTED SPECIFICATIONS AFTER SERVICE WAS PERFORMED ON (B)(6) 2009. THE ARCHITECT SYSTEM OPERATIONS MANUAL (96211-110, SECTION 10) WAS FOUND TO CONTAIN ADEQUATE INFORMATION TO RESOLVE ERRATIC RESULTS ISSUES. THE MANUAL LISTS MULTIPLE PROBABLE CAUSES FOR ERRATIC RESULTS INCLUDING LOOSE TUBING CONNECTIONS, CUVETTE WASHER MALFUNCTION, OPTICS MALFUNCTION, AND HARDWARE FAILURE. THE TOXO IGG, (B)(4), CMV IGG, (B)(4) PACKAGE INSERTS WERE REVIEWED AND WERE FOUND TO CONTAIN ADEQUATE INFORMATION ON SPECIMEN COLLECTION AND PREPARATION, CAUTIONS AND LIMITATIONS OF THE PROCEDURE. THE PACKAGE INSERTS NOTE IT IS IMPORTANT TO FOLLOW THE ROUTINE MAINTENANCE PROCEDURES DEFINED IN THE ARCHITECT SYSTEM OPERATIONS MANUAL FOR OPTIMAL ANALYZER PERFORMANCE, AND IF THE ARCHITECT RESULTS ARE INCONSISTENT WITH CLINICAL EVIDENCE, ADDITIONAL TESTING IS SUGGESTED TO CONFIRM THE RESULT. A SERVICE HISTORY REVIEW FOUND NO ADDITIONAL INCIDENTS OF ARCHITECT I2000SR SERIAL NUMBER (B)(4) GENERATING UNRESOLVED ERRATIC RESULTS. THE CURRENT RATE FOR ARCHITECT I2000SR ERRATIC OCCURRENCES/ MILLION TESTS AND COMPLAINTS/ MILLION TESTS ARE WITHIN EXPECTED ACTION LIMITS. THE ERRATIC PATIENT RESULTS WERE MOST PROBABLY CAUSED BY MULTIPLE ISSUES INCLUDING OPTICS MALFUNCTION, WASH ZONE PROBES MALFUNCTION, LOOSE TUBING, AND A MALFUNCTIONING SAMPLE VALVE SYRINGE. THE ACTUAL CAUSE OF THE SUSPECT PATIENT RESULTS COULD NOT BE DETERMINED WITH THE INFORMATION AVAILABLE. BASED ON THE AVAILABLE INFORMATION AND THIS INVESTIGATION, NO DEFICIENCY WAS IDENTIFIED FOR THE ARCHITECT I2000SR ANALYZER LIST NO. 03M74-02 RELATED TO THE ISSUE UNDER INVESTIGATION. THIS IS THE FINAL REPORT.
THIS IS AN INITIAL REPORT. AN INVESTIGATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE.
THE ACCOUNT STATED THAT THE ARCHITECT I2000SR ANALYZER HAS GENERATED A FALSE REACTIVE TOXOPLASMOSIS IGG RESULT ON A PATIENT SAMPLE. THE INITIAL RESULT WAS 4.0 IU/ML AND THE RETEST RESULT WAS 0 IU/ML. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ARCHITECT I2000SR ANALYZER | AUTOMATED IMMUNOASSAY ANALYZER | JJE | ABBOTT MANUFACTURING, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | TOXO- IGG REAGENT LOT UNKNOWN| CMV IGG REAGENT LOT UNKNOWN |